CD72 negatively regulates signaling through the antigen receptor of B cells

被引:80
作者
Adachi, T
Wakabayashi, C
Nakayama, T
Yakura, H
Tsubata, T
机构
[1] Tokyo Med & Dent Univ, Med Res Inst, Dept Immunol, Bunkyo Ku, Tokyo 1138510, Japan
[2] Chiba Univ, Grad Sch Med, Dept Mol Immunol, Chiba, Japan
[3] Tokyo Metropolitan Inst Neurosci, Fuchu, Tokyo 183, Japan
关键词
D O I
10.4049/jimmunol.164.3.1223
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 [免疫学];
摘要
The immunoreceptor tyrosine-based inhibition motif (ITIM) is found in various membrane molecules such as CD22 and the low-affinity Fc receptor for IgG in B cells and the killer cell-inhibitory receptor and Ly-49 in NK cells. Upon tyrosine phosphorylation at the ITIMs, these molecules recruit SH2 domain-containing phosphatases such as SH2-containing tyrosine phosphatase-l and negatively regulate cell activity. The B cell surface molecule CD72 carries an ITIM and an ITIM-like sequence. We have previously shown that CD72 is phosphorylated and recruits SH2 -containing tyrosine phosphatase-l upon cross-linking of the Ag receptor of B cells (BCR), However, whether CD72 modulates BCR signaling has not yet been elucidated. In this paper we demonstrate that expression of CD72 down-modulates both extracellular signal-related kinase (ERK) activation and Ca2+ mobilization induced by BCR ligation in the mouse B lymphoma line K46 mu m lambda, whereas BCR-mediated ERK activation was not reduced by the ITIM-mutated form of CD72. Moreover, coligation with CD72 with BCR reduces BCR-mediated ERK activation in spleen B cells of normal mice. These results indicate that CD72 negatively regulates BCR signaling. CD72 may play a regulatory role in B cell activation, probably by setting a threshold for BCR signaling.
引用
收藏
页码:1223 / 1229
页数:7
相关论文
共 50 条
[1]
Adachi T, 1998, J IMMUNOL, V160, P4662
[2]
CYTOPLASMIC DOMAIN HETEROGENEITY AND FUNCTIONS OF IGG FC-RECEPTORS IN LYMPHOCYTES-B [J].
AMIGORENA, S ;
BONNEROT, C ;
DRAKE, JR ;
CHOQUET, D ;
HUNZIKER, W ;
GUILLET, JG ;
WEBSTER, P ;
SAUTES, C ;
MELLMAN, I ;
FRIDMAN, WH .
SCIENCE, 1992, 256 (5065) :1808-1812
[3]
Identification of a novel inducible cell-surface ligand of CD5 on activated lymphocytes [J].
Biancone, L ;
Bowen, MA ;
Lim, A ;
Aruffo, A ;
Andres, G ;
Stamenkovic, I .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (03) :811-819
[4]
A role for CD5 in cognate interactions between T cells and B cells, and identification of a novel ligand for CD5 [J].
Bikah, G ;
Lynd, FM ;
Aruffo, AA ;
Ledbetter, JA ;
Bondada, S .
INTERNATIONAL IMMUNOLOGY, 1998, 10 (08) :1185-1196
[5]
BONDADA S, 1984, J EXP MED, V159, P1796
[6]
Defective negative regulation of antigen receptor signaling in Lyn-deficient B lymphocytes [J].
Chan, VWF ;
Lowell, CA ;
DeFranco, AL .
CURRENT BIOLOGY, 1998, 8 (10) :545-553
[7]
Characterization of the B lymphocyte populations in Lyn-deficient mice and the role of Lyn in signal initiation and down-regulation [J].
Chan, VWF ;
Meng, FY ;
Soriano, P ;
DeFranco, AL ;
Lowell, CA .
IMMUNITY, 1997, 7 (01) :69-81
[8]
Polygenic autoimmune traits: Lyn, CD22, and SHP-1 are limiting elements of a biochemical pathway regulating BCR signaling and selection [J].
Cornall, RJ ;
Cyster, JG ;
Hibbs, ML ;
Dunn, AR ;
Otipoby, KL ;
Clark, EA ;
Goodnow, CC .
IMMUNITY, 1998, 8 (04) :497-508
[9]
Tuning antigen receptor signaling by CD22: Integrating cues from antigens and the microenvironment [J].
Cyster, JG ;
Goodnow, CC .
IMMUNITY, 1997, 6 (05) :509-517
[10]
A ROLE IN B-CELL ACTIVATION FOR CD22 AND THE PROTEIN-TYROSINE-PHOSPHATASE SHP [J].
DOODY, GM ;
JUSTEMENT, LB ;
DELIBRIAS, CC ;
MATTHEWS, RJ ;
LIN, JJ ;
THOMAS, ML ;
FEARON, DT .
SCIENCE, 1995, 269 (5221) :242-244